Kjetil Bjørnevik
About
In The Last Decade
Kjetil Bjørnevik
55 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Pathology and Forensic Medicine 1.3k
- Neurology 627
- Immunology 550
- Molecular Biology 497
- Oncology 471
Countries citing papers authored by Kjetil Bjørnevik
This map shows the geographic impact of Kjetil Bjørnevik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kjetil Bjørnevik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kjetil Bjørnevik more than expected).
Fields of papers citing papers by Kjetil Bjørnevik
This network shows the impact of papers produced by Kjetil Bjørnevik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kjetil Bjørnevik. The network helps show where Kjetil Bjørnevik may publish in the future.
Co-authorship network of co-authors of Kjetil Bjørnevik
This figure shows the co-authorship network connecting the top 25 collaborators of Kjetil Bjørnevik. A scholar is included among the top collaborators of Kjetil Bjørnevik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kjetil Bjørnevik. Kjetil Bjørnevik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Title | Journal | Authors | Indexed citations |
|---|---|---|---|---|
| 1 | Comparative effectiveness of rituximab and cladribine in relapsing–remitting multiple sclerosis: A target trial emulation | Multiple Sclerosis Journal | Einar August Høgestøl, Øivind Torkildsen et al. | 0 |
| 2 | Plasma Metabolomics Profiles in Prodromal and Clinical Parkinson's Disease | Movement Disorders | Sarah Jeanfavre, Clary B. Clish et al. | 0 |
| 3 | EBV and Autoimmunity | Current topics in microbiology and immunology | Marianna Cortese, Alberto Ascherio et al. | 0 |
| 4 | Coeliac disease as a model for understanding multiple sclerosis | Nature Reviews Neurology | Kjetil Bjørnevik, Marianna Cortese et al. | 1 |
| 5 | Identifying Individuals in the Prodromal Phase of Parkinson's Disease: A Prospective Cohort Study | Annals of Neurology | Katherine C. Hughes, Marianna Cortese et al. | 2 |
| 6 | Antiviral therapy with tenofovir in MS | Multiple Sclerosis and Related Disorders | Øivind Torkildsen, Kjell‐Morten Myhr et al. | 7 |
| 7 | Flavonoid intake and risk of Parkinson’s disease | Journal of Neurology Neurosurgery & Psychiatry | Helena Sandoval‐Insausti, Kjetil Bjørnevik et al. | 0 |
| 8 | Long‐Term Intake of Folate, Vitamin | Movement Disorders | Chadwick W. Christine, Kjetil Bjørnevik et al. | 12 |
| 9 | Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes | Annals of Neurology | Natalia Palacios, Jeremy E. Wilkinson et al. | 30 |
| 10 | Subjective Cognitive Decline in Women with Features Suggestive of Prodromal Parkinson's Disease | Movement Disorders | Kjetil Bjørnevik, Albert Y. Hung et al. | 5 |
| 11 | Childbirth delivery mode and the risk of multiple sclerosis: a prospective population-based study | Journal of Neurology Neurosurgery & Psychiatry | Anne Kjersti Daltveit, Kjell‐Morten Myhr et al. | 0 |
| 12 | Smoking and multiple sclerosis risk in black people: A nested case-control study | Multiple Sclerosis and Related Disorders | Marianna Cortese, Kassandra L. Munger et al. | 1 |
| 13 | Hair color, family history of melanoma, and the risk of Parkinson's disease: An analysis update | Parkinsonism & Related Disorders | Kjetil Bjørnevik, Xinyuan Zhang et al. | 2 |
| 14 | Epstein–Barr virus as a leading cause of multiple sclerosis: mechanisms and implications breakdown → | Nature Reviews Neurology | Kjetil Bjørnevik, Christian Münz et al. | 128 |
| 15 | A Prospective Study of Serum Levels of Polyunsaturated Fatty Acids and Effects on Multiple Sclerosis Disease Activity and Progression (S40.006) | Neurology | Kassandra L. Munger, Kjetil Bjørnevik et al. | 2 |
| 16 | Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis | Multiple Sclerosis and Related Disorders | Kristin Wesnes, Kjell‐Morten Myhr et al. | 15 |
| 17 | Tenofovir as a treatment option for multiple sclerosis | Multiple Sclerosis and Related Disorders | Øivind Torkildsen, Kjell‐Morten Myhr et al. | 11 |
| 18 | Urate and the risk of Parkinson's disease in men and women | Parkinsonism & Related Disorders | Marianna Cortese, Trond Riise et al. | 42 |
| 19 | Body size and physical exercise, and the risk of multiple sclerosis | Multiple Sclerosis Journal | Marianna Cortese, Trond Riise et al. | 28 |
| 20 | Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study | Multiple Sclerosis Journal | Andreas Lossius, Trond Riise et al. | 36 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.